Pricing Log in Create free account

Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) vs Seelos Therapeutics, Inc. (SEELQ)

Scinai Immunotherapeutics Ltd. Sponsored ADR and Seelos Therapeutics, Inc. are both Biotechnology companies. Scinai Immunotherapeutics Ltd. Sponsored ADR and Seelos Therapeutics, Inc. are of similar size ($700.0K and $640.0K). Seelos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Seelos Therapeutics, Inc. leads on 7 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 5.

Valuation

Metric SCNI SEELQ Biotechnology median
P/E 0.01 n/m 8.50
P/S n/m n/m 9.71
P/B 0.05 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.28 n/m 0.64
EV/Sales n/m 0.50 9.21
Earnings yield 11,368.55% 0.00% (33.15%)
Free cash flow yield (2,331.48%) 0.00% (25.50%)

Profitability

Metric SCNI SEELQ Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity 0.00% (10.86%) (56.36%)
Return on assets 0.00% 57.34% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SCNI SEELQ Biotechnology median
Revenue growth (TTM) — (51.45%) 6.02%
EPS growth (last fiscal year) (159.83%) 62.72% 30.26%
Revenue growth, 5-year CAGR — (22.63%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SCNI SEELQ Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.56 0.08 4.72
Net debt to EBITDA 0.25 0.09 0.96

Dividend

Metric SCNI SEELQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SCNI SEELQ Biotechnology median
Market cap 640.00k 700.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack